...
首页> 外文期刊>European review for medical and pharmacological sciences. >Long non-coding RNA MIR155HG knockdown suppresses cell proliferation, migration and invasion in NSCLC by upregulating TP53INP1 directly targeted by miR-155-3p and miR-155-5p
【24h】

Long non-coding RNA MIR155HG knockdown suppresses cell proliferation, migration and invasion in NSCLC by upregulating TP53INP1 directly targeted by miR-155-3p and miR-155-5p

机译:长期非编码RNA miR155Hg敲低通过上调MIR-155-3P和MIR-155-5P直接针对的TP53INP1抑制了NSCLC中的细胞增殖,迁移和侵袭

获取原文
           

摘要

OBJECTIVE: Previous studies have proved that lncRNA MIR155 host gene (MIR155HG) is overexpressed in glioma and has elucidated its function. However, its functional role and underlying molecular mechanism in non-small cell lung cancer (NSCLC) are unknown. This study aimed to investigate the function and underlying mechanism of MIR155HG in NSCLC. MATERIALS AND METHODS: Differentially expressed lncRNAs in NSCLC tissue were identified from Gene Expression Omnibus (GEO) database. The expression of MIR155HG, miR-155-3p, miRNA-155-5p, and tumor protein p53-inducible nuclear protein 1 (TP53INP1) in NSCLC specimens and cells were quantified using quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blotting analysis. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and transwell invasion assay were performed to evaluate cell viability and the ability of migration and invasion. Luciferase reporter assay was employed to examine whether miR-155-3p and miR-155-5p could bind to TP53INP1 in NSCLC cells. A xenograft tumor model was used to evaluate the biological function of MIR155HG in vivo. RESULTS: Data obtained from the GEO dataset show that MIR155HG is frequently overexpressed in NSCLC tumor tissues and cell lines. Elevated MIR155HG levels were found to be associated with advanced disease stage and poor prognosis of NSCLC. Cell viability, as well as the capability of migration and invasion of NCI-H1975 and A549 cells, was markedly reduced upon MIR155HG knockdown. Mechanistically, bioinformatics analysis and functional assays confirmed that miR-155-5p and miR-155-3p, two derivatives of MIR155HG, contributed to the effect of MIR155HG in NSCLC. It was also found that miR-155-5p or miR-155-3p mimics could dramatically rescue the inhibition of cell proliferation, migration, and invasion caused by siMIR155HG. Furthermore, bioinformatics analysis and Luciferase reporter assays revealed that miR-155-5p and miR-155-3p mediate the effect of MIR155HG in NSCLC cells by negatively regulating the tumor suppressor TP53INP1. CONCLUSIONS: Current findings indicate that MIR155HG/miR-155 axis facilitates NSCLC progression by downregulating TP53INP1. Therefore, the MIR155HG/miR-155 axis may be a potential therapeutic target for NSCLC.
机译:目的:先前的研究证明,LNCRNA miR155宿主基因(mir155hg)在胶质瘤中过表达,并阐明了其功能。然而,其非小细胞肺癌(NSCLC)中的功能作用和潜在的分子机制是未知的。本研究旨在探讨NSCLC MIR155HG的功能和基础机制。材料和方法:从基因表达OMNIBUS(GEO)数据库中鉴定了NSCLC组织中的差异表达的LNCRNA。使用定量实时 - 聚合酶链反应(QRT-PCR)来定量MiR155Hg,miR-155-3p,miRNA-155-3p,miRNA-155-5p,miRNA-155-5p和肿瘤蛋白P53-诱导核蛋白1(TP53Inp1)和细胞Western Blotting分析。进行3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑鎓溴(MTT)测定和Transwell侵袭测定以评估细胞活力和迁移和侵袭能力。使用荧光素酶报告器测定检查MIR-155-3P和MIR-155-5P是否可以在NSCLC细胞中结合TP53INP1。异种移植肿瘤模型用于评价体内miR155Hg的生物学功能。结果:从Geo数据集获得的数据显示,MiR155Hg在NSCLC肿瘤组织和细胞系中经常过表达。发现升高的miR15Hg水平与晚期疾病阶段和NSCLC预后差有关。在MiR155HG敲低时显着降低了细胞活力,以及NCI-H1975和A549细胞的迁移和侵袭的能力。机械地,生物信息学分析和功能测定证实,MIR-155-5P和MIR-155-3P,MIR155HG的两种衍生物有助于MIR155HG在NSCLC中的作用。还发现miR-155-5p或miR-155-3p模仿可以显着拯救由SIMIR155HG引起的细胞增殖,迁移和侵袭的抑制。此外,生物信息学分析和荧光素酶报告器测定显示MiR-155-5P和MIR-155-3P通过对肿瘤抑制器TP53InP1负面调节MiR155Hg在NSCLC细胞中的影响。结论:目前发现表明,MiR155HG / miR-155轴通过下调TP53InP1促进NSCLC进展。因此,MiR155HG / miR-155轴可以是NSCLC的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号